WHO ICTRP trial
A Phase 3 Randomized, Placebo- and Active Comparator-Controlled Clinical Trial…
EUCTR2007-003820-40-LT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-003820-40-LT |
|---|---|
| Public title | A Phase 3 Randomized, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of Two Doses of Lurasidone HCl in Acutely Psychotic Patients with Schizophrenia |
| Scientific title | A Phase 3 Randomized, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of Two Doses of Lurasidone HCl in Acutely Psychotic Patients with Schizophrenia |
| Primary sponsor | Dainippon Sumitomo Pharma America, Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Lithuania |
| Conditions | Schizophrenia MedDRA version: 9.1 Level: LLT Classification code 10039626 Term: Schizophrenia |
| Interventions | Product Name: lurasidone HCl Product Code: SM-13496 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: lurasidone HCl CAS Number: 367514-88-3 Current Sponsor code: SM-13496 Concentration unit: mg milligram(s) Concentration type… |
| Registration date | Dec 29, 2007 |
| Target size | 490 |
| Secondary IDs | D1050231 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: